14
14
14
Table 2 Antibiotic (Ab) enchancing activity of silver nanoparticles synthesized by Pleurotus sajor caju against the
test organisms MRSA, S. aureus, P. aeruginosa and E.coli.
A ntibiotics MRSA S.aureu s P.aeruginosa E. coli
Ab A b+A gN [B]2- Ab Ab+AgN [ B] 2- Ab Ab+ A [B]2-[A ] Ab A b+A g
[A] ps[B] [A] 2 [A] ps [A] 2/ [A ] gN p[B] 2
/[A ]2 [A ] N p[B] [B]2-[A]
(mm) (mm) /[A ]2 (mm) [B](mm) [A ]2 (mm) (mm) (mm) (mm)
Penicillin 8 12 1. 25 - 14 4.44 - 22 12.4 - 18 8
Methicillin - 18 8 - 12 3 - 24 15 - 16 6.11
Am oxycillin 20 30 1. 25 7 20 7.1 - 22 12.4 20 30 1.25
Am picillin 10 12 0. 44 - 23 13.6 - 20 10.11 7 24 10.75
Where 'A' : Zone of inhibition by antibiotic only ; 'B' : Zone of inhibition in combination with Antibiotic and AgNps
78 Potential of Pleurotus sajor caju to synthesize Silver nanoparticles and evaluation of antibacterial activity and their role as antibiotic activity enhancer